Filter Results
:
(108)
Show Results For
-
All HBS Web
(144)
- News (22)
- Research (108)
- Events (2)
- Multimedia (2)
- Faculty Publications (41)
Show Results For
-
All HBS Web
(144)
- News (22)
- Research (108)
- Events (2)
- Multimedia (2)
- Faculty Publications (41)
←
Page 6 of
108
Results
Sort by
- 20 Jan 2017
- Research & Ideas
Here’s How Businessman Trump Is Likely to Approach the Presidency
approval rating. That will require him to hone his communications skills and to win over many people who remain skeptical of his motives and competency. He must consciously set out to escape the Washington bubble and stay in touch with...
View Details
Keywords:
by Christina Pazzanese
- 12 Feb 2019
- First Look
New Research and Ideas, February 12, 2019
collection and privacy. Finally, we discuss emerging challenges surrounding software-driven medical devices, including open regulatory questions, advancements in underlying digital technology, and the likely necessity of new payment and...
View Details
Keywords:
Dina Gerdeman
- 06 Jun 2017
- First Look
First Look at New Research and Ideas: June 6, 2017
regulatory pathway, the biosimilars pathway, on the strategy of a major pharmaceutical firm that finds its largest product (60% of revenue) at risk. The case reviews the rationale for the pathway, the emerging biosimilars market entrants,...
View Details
Keywords:
Sean Silverthorne
- 12 Jan 2016
- First Look
January 12, 2016
medical devices after they are approved by the appropriate regulatory authorities. Historically, such surveillance was based on voluntary reports by medical practitioners, but with the widespread adoption of...
View Details
Keywords:
Carmen Nobel
- 19 Jun 2007
- First Look
First Look: June 19, 2007
addition, firms with more KLD concerns have slightly, but statistically significantly, more pollution and regulatory compliance violations in later years. KLD environmental strengths, in contrast, do not accurately predict pollution...
View Details
Keywords:
Martha Lagace
- ←
- 6